ClinicalTrials.Veeva

Menu

Cerebellar High-Frequency rTMS in Balance of Multiple Sclerosis Patients (CRESTMS)

A

Ain Shams University

Status

Completed

Conditions

Multiple Sclerosis

Treatments

Device: cerebellar rTMS

Study type

Interventional

Funder types

Other

Identifiers

NCT06998810
FMASU R31/2023
FMASUREC (Other Identifier)

Details and patient eligibility

About

Background: Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system (CNS), leading to progressive motor dysfunction and balance deficits. Objective: To investigate the impact of cerebellar rTMS in improving postural control, balance performance and functional ambulation in individuals with MS.

Forty patients were randomly assigned to receive repetitive transcranial magnetic stimulation (rTMS) over the cerebellum to improve motor function and balance in 40 MS patients. Outcome measures, including the Expanded Disability Status Scale (EDSS), static posturography (COP measures), the International Cooperative Ataxia Rating Scale (ICARS), and the 10-Meter Walk Test (10MWT), were assessed before and after intervention.

Full description

Background: Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system (CNS), leading to progressive motor dysfunction and balance deficits. Although disease-modifying therapies have advanced, there remains an unmet need for effective treatments that target motor and cognitive impairments. Objective: To investigate the impact of cerebellar rTMS in improving postural control, balance performance, and functional ambulation in individuals with MS. Method: This randomized, single-blinded, placebo-controlled clinical trial evaluated the efficacy of repetitive transcranial magnetic stimulation (rTMS) over the cerebellum in improving motor function and balance in 40 MS patients. Outcome measures, including the Expanded Disability Status Scale (EDSS), static posturography (COP measures), the International Cooperative Ataxia Rating Scale (ICARS), and the 10-Meter Walk Test (10MWT), were assessed before and after intervention.

Enrollment

40 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient age ≥18 years.
  • Patients with MS, established by clinical, laboratory, MRI criteria and matched Mc Donald's criteria, McDonald et al, 2006.
  • Expanded Disability Status Scale (EDSS) scores between 2.5-5
  • Only patients in "remitting" phase were included.
  • Informed consent.

Exclusion criteria

  • Factors that prevent patient cooperation understanding that impede proper study participation.

  • Disabling medical history as severe or recent heart disease and or severe head trauma.

  • Cognitive impairment: <24 points by mini-mental scale. (Folstein MF et al., 1975).

  • Diabetic patients.

  • Patients with any other comorbidity that can affect balance, e.g, other neurological diseases that can affect posterior column function.

  • Contraindications for rTMS:

    1. History of epilepsy.
    2. Metal (implants) in skull/scalp/head or fragments from welding or metalwork.
    3. Implanted device (as spinal cord stimulator, cardiac pacemaker, and cochlear implants).
    4. Pregnancy.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups

Arm 1: Active Comparator - Real rTMS
Active Comparator group
Description:
Arm Label: Real rTMS Type: Active Comparator Description: Participants in this group receive real repetitive transcranial magnetic stimulation (rTMS) targeting the cerebellum. Stimulation is delivered using a figure-of-eight coil positioned over the vermis of the cerebellum, at a frequency of 10 Hz, work period 5s, number of trains 25, ITI is 25s. The total number of pulses is 1250 pulses per session.
Treatment:
Device: cerebellar rTMS
Arm 2: Sham Comparator - Sham rTMS
Sham Comparator group
Description:
Arm Label: Sham rTMS Type: Sham Comparator Description: Participants in this group receive sham stimulation using the same rTMS device and setup as the active group. The coil is adjusted to mimic the sound and feel of stimulation without delivering an effective magnetic pulse to the brain. Participants are blinded to their assignment to preserve study integrity.
Treatment:
Device: cerebellar rTMS

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems